Byeong‐Keuk Kim

Ewha Womans University — South Korea

Medicine · Health Sciences

50h-index14.8kcitations580works6.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Coronary Interventions and Diagnostics(361), Antiplatelet Therapy and Cardiovascular Diseases(164), Acute Myocardial Infarction Research(132), Cardiac Imaging and Diagnostics(131), Peripheral Artery Disease Management(75)

Publications571 total

Prognostic Implication of <i>CYP2C19</i> Genotype According to Clinical Risk Stratification After Drug‐Eluting Stent Implantation
Clinical Pharmacology & Therapeutics·2025· 1 cited
Sex differences in platelet reactivity and five-year outcomes with extended dual antiplatelet therapy after drug-eluting stent implantation
Hellenic Journal of Cardiology·2025Open Access
Optical coherence tomography-guided stent optimization for complex coronary lesions: the OCCUPI trial
European Heart Journal·2025· 2 cited
Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents
New England Journal of Medicine·2025· 10 cited
Optical coherence tomography-guided percutaneous coronary intervention in acute coronary syndrome patients with complex lesions: a subgroup analysis of the randomised OCCUPI Trial
EuroIntervention·2025
TCT-921 Comparison of Skin Perfusion Pressure and Transcutaneous Oxygen Pressure for Predicting Early Wound Healing After Endovascular Therapy in Patients With Chronic Limb-Threatening Ischaemia
Journal of the American College of Cardiology·2025
TCT-56 Impact of age on the efficacy and safety of ticagrelor monotherapy in patients with acute coronary syndrome: A pooled analysis from the TICO and T-PASS Trials
Journal of the American College of Cardiology·2025
TCT-112 The Processing of Stent Optimization Using Optical Coherence Tomography After Angiography-Guided Stent Implantation: Pre-specified Analyses of the OCCUPI Randomized Trial
Journal of the American College of Cardiology·2025
TCT-680 Clinical effect of OCT-Guided PCI in Patients with Diabetes Mellitus: A prespecified substudy from the OCCUPI Trial
Journal of the American College of Cardiology·2025
TCT-460 Twenty-four–month Outcomes of Intravascular Ultrasound-Guided Drug-Coated Balloon Angioplasty for Femoropopliteal Artery Disease
Journal of the American College of Cardiology·2025
TCT-698 Impact of Optical Coherence Tomography-Guided Percutaneous Coronary Intervention for the Complex Lesions According to Lesion Length and Vessel Diameter: Results from the OCCUPI Randomized Trial
Journal of the American College of Cardiology·2025
Long-Term Impact of Platelet Reactivity and Clinical Risk on Clinical Outcomes in Patients With Coronary Artery Disease: Analysis of the PTRG-DES Registry
Circulation Cardiovascular Interventions·2025
Validation of Intravascular Ultrasound–Defined Optimal Stent Expansion Criteria for Favorable 1-Year Clinical Outcomes
JACC: Cardiovascular Interventions·2025· 3 cited
Twenty‐Four–Month Outcomes of Intravascular Ultrasound‐Guided Drug‐Coated Balloon Angioplasty for Femoropopliteal Artery Disease
Journal of the American Heart Association·2025· 1 citedOpen Access
Decoding Bleeding Risks and Survival in Patients Undergoing Percutaneous Coronary Intervention on Antiplatelet Therapy
JACC Asia·2025· 3 citedOpen Access
Alternative LDL cholesterol-lowering strategy versus high-intensity statin strategy in patients with diabetes and ASCVD: An individual patient data meta-analysis from the racing and lodestar trials
Atherosclerosis·2025
Prognostic implication of venoarterial extracorporeal membrane oxygenation in acute myocardial infarction-related cardiogenic shock
Journal of Intensive Care·2025Open Access
Comparison of rosuvastatin 10 mg plus ezetimibe versus rosuvastatin 20 mg in atherosclerotic cardiovascular disease and type 2 diabetes
Scientific Reports·2025· 1 citedOpen Access
Obicetrapib–ezetimibe combination therapy for patients with atherosclerotic cardiovascular disease
The Lancet·2025· 1 cited
Potassium-competitive acid blocker vs proton-pump inhibitor in patients receiving antithrombotic therapy who are at high risk for gastrointestinal bleeding: Rationale and design of the randomized PROTECT- HBR trial
American Heart Journal·2025
page 1 of 29Next →

Frequent Co-authors

Yangsoo Jang(49), Myeong‐Ki Hong(46), Jung‐Sun Kim(38), Donghoon Choi(36), Young‐Guk Ko(35), Sung‐Jin Hong(24), Dong‐Ho Shin(20), Chul‐Min Ahn(17), Seung‐Jun Lee(11), Woong Chol Kang(10), Bum‐Kee Hong(10), Marco Valgimigli(10), Seung‐Ho Hur(8), Hyo‐Soo Kim(8), Gregg W. Stone(8), Yong‐Joon Lee(8), Tae Soo Kang(7), Yong Hoon Kim(7), Tullio Palmerini(7), Fausto Feres(7)